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ORIGINAL ARTICLE
Surgical outcomes and the impact of major surgery on
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hidradenitis suppurativa patients: a prospective single
centre study
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Abstract
Background Hidradenitis suppurativa (HS) is a chronic debilitating skin disease, frequently located in the groin
and anogenital area, leading to a substantial impact on quality of life and sexual health in patients with HS. Skin-tissue-
sparing excision with electrosurgical peeling (STEEP) is a procedure with known low recurrence rates and high patient
satisfaction in retrospective series. However, a prospective study to investigate the impact of any major surgery on
speciﬁc aspects of the quality of life has not yet been performed.
Objective To assess surgical outcomes and the effect of major surgery on the general quality of life, sexual health and
activity impairment in patients with HS.
Materials and methods A single centre prospective survey study was conducted among 40 patients undergoing
major surgery. Surveys were completed prior to the surgery and 2, 6, 12 and 26 weeks after surgery. Besides the objec-
tive parameters (time to wound closure and surface of the wound), patient-reported outcomes were reported.
Results Thirty-nine patients with a total of 171 survey responses were included for analysis. Patients with Hurley stage
I or II had a shorter time to wound closure (TTWC) compared to patients with Hurley stage III (P = 0.005). TTWC was sig-
niﬁcantly prolonged in patients treated with biologics (P < 0.001). Smoking did not signiﬁcantly inﬂuence TTWC. For
patient-reported outcomes, DLQI and ASEX scores did not signiﬁcantly improve during the study period of 6 months.
However, activity and overall work impairment showed considerable improvement after surgery.
Conclusion Time to wound closure is signiﬁcantly prolonged by higher Hurley stage and treatment with biologics, con-
trastingly not by smoking. Major surgery improved the overall work and daily activity impairment.
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Hidradenitis suppurativa (HS) is a chronic debilitating skin dis-
ease with an estimated prevalence of 1% in the general popula-
tion.1,2 Recurrent painful nodules and abscesses, subsequently
leading to formation of sinus tracts and scarring, are the main
features.1 Since the disease is frequently located in the groin and
anogenital area, patients suffering from HS experience an sub-
stantial impact on quality of life and sexual health.3,4 Surgical
interventions play a key role in the treatment of chronic HS.5–7
By excising the affected, painful skin, local disease control can be
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achieved. As described by Blok et al.,8 skin-tissue-sparing exci-
sion with electrosurgical peeling (STEEP) is a procedure with
low recurrence rates and high patient satisfaction. This proce-
dure is comparable to a wide excision, with the primary aim to
maximally spare healthy tissue. This is achieved by performing
successive tangential excisions of affected tissue until an epithe-
lialized bottom of a sinus tract is reached. Any fibrotic tissue will
be removed in the same manner.8 So far, prospective studies to
investigate the effect of major surgery on aspects of the quality
of life have not been done in patients with HS. Therefore, we
sought to assess the impact of surgery on the general quality of
life of patients with HS and, more specific, on sexual health and
activity impairment. Additionally, surgical outcomes, such as
time to wound closure, were also assessed.
Material and methods
Study design and subjects
A prospective, survey-based study was conducted at the Univer-
sity Medical Center Groningen from January 2016 through
December 2017. Consecutive patients with a diagnosis of HS,
who underwent major surgery under general anaesthesia, were
included. Informed consent was obtained from each patient.
Adequate knowledge of the Dutch language was mandatory, since
the survey was only available in Dutch. The survey consisted of
thirty-five questions and was completed online by the patients
using a web-based survey tool (Qualtrics 2018, Provo, Utah),
prior to the surgery and 2, 6, 12 and 26 weeks after surgery. If
extra visits outside scheduled timeframes occurred, the number
of postoperative days was registered instead. At the last study
visit, the patients’ electronic file was analysed for objective surgi-
cal outcome measures. One year after the last patient’s study visit,
all records were screened for disease relapses in the operated area.
The local medical ethical committee from UMCG granted
exemption from reviewing our protocol as the treatment was
considered standard of care.
Outcome measures
Patients’ characteristics From all patients, gender, age, body
mass index, smoking status and the refined Hurley classification
were registered.
Surgical outcomes For all participants, the following surgery-
related objective outcomes were assessed: time to wound closure
(TTWC) in days, size of the wound in cm2, location of the surgi-
cal site, relapse rate, complications and the use of a biological
around the time of surgery. A relapse was defined as recurrence
of an inflammatory lesion within 5 mm of the operated area.
Patient-reported outcome measures (PROMs) The DLQI is a
widely used tool to assess quality of life consisting of ten
questions with a minimum score of 0, no impact on quality of
life and maximum score of 30, meaning a maximum impact on
quality of life.9 The WPAI questionnaire was adjusted for HS
(WPAI-HS). Outcomes are expressed as impairment percentages
for the following categories: per cent work time missed due to
HS; per cent impairment while working due to HS; per cent
overall work impairment due to health; and per cent activity
impairment due to HS. Higher percentages indicate a greater
impairment.10,11
The ASEX assesses sexual dysfunction through five questions,
specified per sex. A total score of 19 or higher, or any single item
with a score of 5 or higher or any three items with a score of 4 or
higher indicates sexual dysfunction for both men and women.12
For the pain assessment, the numeric rating scale (NRS) for pain
was used. Patients were asked to score their pain at that moment
from 0 to 10, with 0 indicating no pain and 10 the worst possible
pain.
Statistics
All continuous outcomes were described as mean  SD. The
WPAI outcomes are presented as percentages. In case of missing
values in the DLQI, WPAI or ASEX, the total scores were not
calculated. The patient-reported outcomes with repeated mea-
sures and with a normal distribution analyses were performed
using linear mixed models. The surgical outcomes were analysed
with descriptive statistics, linear regressions and independent t-
tests, depending on the variables. A P < 0.05 was considered sig-
nificant. Statistical analysis was performed using IBM SPSS




A total of 40 patients were included; from them, 175 survey
responses were received. One participant withdrew from the
study before undergoing surgery. Three responses were excluded
from analysis because a correct study identification number was
missing from the survey. For analysis, 171 responses from 39
participants were included.
Participants had a mean age of 39.5  11.1 years, and the
majority of respondents was female (87.2%). Almost 75% of the
participants had a refined Hurley stage of IIB or higher.13 The mean
body mass index for both genders was 29.0  5.5 kg/m2. An over-
view of the baseline characteristics is shown in Table 1.
Surgical outcomes
An overview of the surgical outcomes is shown in Tables 2 and
3. The majority of subjects (69.2%) underwent surgery of the
groin or anogenital area. The approximated surface of the
wound directly postsurgery varied from 6 to 450 cm2 with a
mean of 74.0  86.8 cm2. TTWC was on average
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81.3  48.9 days for all subjects. In our study, the variables age,
gender, BMI and smoking status were not related to TTWC. We
additionally compared patients with a healthy BMI (≤25) to
patients with a BMI >25 and found no difference in TTWC
(P = 0.230) with a comparable mean wound surface between
these groups.
The Hurley stage of the patient was of significant influence on
the TTWC (P = 0.005). Subjects with Hurley stage I or II had a
significant shorter TTWC (34.7  6.4; P = 0.031 and
75.8  37.6 days; P = 0.001 respectively), compared to subjects
with Hurley stage III with an average TTWC of
155  68.2 days. However, the average surface of the wound in
subjects with Hurley III was significantly greater than subjects
with Hurley I (P = 0.046), but comparable between Hurley II
and Hurley III (P = 0.072). There was a significant relationship
found between the surface of the wound and TTWC
(P = 0.002), a larger the wound surface corresponded with a
longer TTWC.
In our study, five patients were treated with biologics. An
overview of their characteristics can be found in Table 4. Patients
were started on biologics due to severe HS or presence of
another inflammatory disease, i.e., psoriasis (patient 9) and
Crohn’s disease (patient 28). Four patients started biologic treat-
ment at least 3 months prior to the surgery, and the other
patient started within 2 months after surgery. Four patients
received adalimumab 40 mg weekly and one infliximab 500 mg
every 6 weeks. Administration of adalimumab was withheld in
all patients in the week of their surgery, and infliximab was
administered 2 weeks after surgery. Data on wound closure were
available from four patients. They showed a prolonged TTWC
with a mean of 185  25.4 days, compared with 68  32.1 days
for participants without biologic treatment (P < 0.001). Wound
surface was comparable for the biologic and non-biologic treated
participants (P = 0.282). Using the chi-square test (Fisher’s
exact test), no differences were found in smoking status for the
biologic and non-biologic group (P = 0.082). No relapses were
reported for these five patients, with a mean follow-up period of
17 months. At this point, two patients discontinued their treat-
ment and three had no change of treatment.
The overall relapse rate was 23.7% with a mean follow-up per-
iod of 12 months. Pain after surgery was reported in 38.5% of
the participants. Complications occurred in 25.6% of all sub-
jects. These included bleeding or hypergranulation of the
wound, which accounted for 90% of all complications. No post-
operative infections were reported.
Patient-reported outcomes
In all patient-reported outcomes, a higher score was related to
more burden or impact. A decrease in the score is therefore a
positive outcome. Overviews of the mean scores of the DLQI,
WPAI-HS and ASEX during the study are shown in Fig. 1a–c.
Dermatology life quality index (DLQI) The mean DLQI score at
baseline was 15.3  6.7 points, equal for men and women
(P = 0.909). When comparing the DLQI scores for each time
point to baseline, no significant differences were found. Instead
of comparing the scores for each individual time point, we also
analysed the trend over time. This showed slightly increasing
DLQI scores in the first 3 months after surgery to 17.3, which
then decreased steadily to 15.4 at 6 months. There was a signifi-
cant difference in mean DLQI scores between time points
(P = 0.047). The nature of this mixed model trend analysis does
not specify between which exact time points, this significant dif-
ference is present. Both age and gender did not influence the
mean DLQI score (P = 0.117 and P = 0.882, respectively). A
similar trend for DLQI scores was found when patients with a
relapse were excluded.
Work productivity and activity impairment questionnaire:
WPAI-HS Activity impairment. At baseline, subjects reported
an average impairment on daily activities of 40.4%, with no dif-
ferences between men and women. Two weeks postsurgery, this
increased significantly to 59.7% (P = 0.039) but decreased stea-
dily to 18.8% at 6 months (P = 0.104), when comparing each
time point individually to baseline. Analysis for trend showed no
influence from age or gender on activity impairment.
Table 1 Patient characteristics
N = 39
Age (years  SD) 39.5  11.1
Gender
Male (%) 5 (13%)
Female (%) 34 (87%)
Body mass index (kg/m2) 29.0  5.5
Smoking status








Biologics use 5 (13%)
Table 2 Frequencies surgical sites
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Table 3 Surgical outcomes
N* Mean wound surface (cm2)  SD P Mean TTWC (days)  SD P
TTWC 35 81.3  48.9
Wound surface 38 74.0  86.8 0.002†
Biologics
Yes 4 118.8  86.8 0.282‡ 185  25.4 <0.0001‡
No 34 68.8  86.4 67.9  32.1
Smoking
Yes 26/24 67.9  65.9 0.531‡ 68.5  34.4 0.070‡
No 12 87.3  123.2 109.4  64.5
Hurley stage
I 4/3 18.8  14.4 0.046§ 34.7  6.4 0.031§
II 30/28 58.6  53.9 0.072§ 75.8  37.6 0.001§
III 4 245  138.2 155  68.2
BMI 39 0.102†
≤25 9/10 42.4  62.1 0.216‡ 68.6  30.4 0.230‡
>25 29/25 83.8  91.8 86.4  54.3
*Number of patients with data available per outcome.
†Regression analysis with outcome variable TTWC.
‡Independent samples t-test.
§Independent samples t-test with Hurley I and Hurley II being compared with the Hurley III group.
Table 4 Characteristics of patients with biologic treatment


























6 F 51 36.7 No* III Adalimumab 40 mg QW Before 14 Yes No
9 F 34 28.7 No* IIB Adalimumab 40 mg QW Before 13 Yes No
24 M 26 33.0 Yes† III Inﬂiximab 500mg E6W Before 184§ Yes No
28 F 44 25.7 Yes IIB Adalimumab 40 mg QW Before 221 Yes No




§Estimation: no exact start date was reported.
















Mean overall DLQI score











































Figure 1 (a) Mean overall DLQI score. (b) Mean overall WPAI-HS-scores. *Signiﬁcant increase in activity impairment at week 2
(P = 0.039). (c) Mean ASEX score.
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Overall work impairment On average, the overall work impair-
ment at baseline was 25.0%, equal for both genders. Similar to
the activity impairment, in the first 2 weeks after surgery there
was an increase in overall work impairment to 46.4%. In the
next 4 weeks, that score decreased to 31.6% and this continued
to ultimately 7.9% at 6 months, however not significant. Analy-
sis for trend showed no influence from age or gender on overall
work impairment.
The other domains (percentage work missed due to HS and
impairment while working) showed similar trends, a slight
increase followed by a steady decrease. Both were not significant.
Arizona sexual experiences scale: ASEX At baseline, the mean
ASEX score was 15.4  4.5 points and did not differ between
both genders (P = 0.77). Nine respondents (22.5%) met the cri-
teria for sexual dysfunction at one or more time points. Three
months postsurgery, the mean overall score showed a small
improvement to 14.4 points, however not significant
(P = 0.443). At 6 months, the average ASEX scores were compa-
rable again to baseline. The trend analysis showed a significant
influence from age on the average ASEX score (P = 0.008). We
further analysed this through independent sample t-tests, com-
paring the scores for participants ≤35 years and ≥36 years at
baseline (n = 27), 3 (n = 16) and 6 months (n = 9) postsurgery.
There was a difference in ASEX scores for all time points
between the groups, with a significant difference at 6 months
(18.0 vs 13.5 points for the ≥36 years group; P = 0.02).
Pain level Mean pain intensity at baseline was 2.8  2.4 points
out of 10. After 2 weeks, patients reported an average pain level
of 3.3 points, which decreased to 1.6 points at 6 months, both
not significant. However, the effect of time on the level of pain
was significant (P = 0.029). Trend analysis showed no additional
influence from age or gender.
Discussion
In this prospective single centre study, we assessed the influence
of major surgery on the general quality of life, work and activity
impairment and sexual health in patients with HS. We found
that patients with Hurley stage I or II had a shorter TTWC com-
pared to patients with Hurley stage III and TTWC was signifi-
cantly prolonged in patients treated with biologics. Furthermore,
a larger wound surface area was significantly related to pro-
longed TTWC.
For the Hurley stage, this can partially be explained by a sub-
stantial difference in wound surface between Hurley I and Hur-
ley III. Notably, body mass index and smoking were not
significantly related to time to wound closure in our study.
Dixon et al.14 described no increased risk of wound complica-
tions for smokers in a cohort of 4197 patients who underwent
excisions for skin malignancies. Most reported wound complica-
tions due to smoking are wound dehiscence, necrosis of a flap or
graft, prolonged healing time and infections. However, studies
assessing wound healing mainly focus on healing of acute
wounds, rather than secondary wound healing, which could
explain our somewhat contrasting findings.15,16 Further studies
on the effect of smoking on secondary wound healing are neces-
sary.
All procedures in this study were done under general anaes-
thesia. Another convenient option for patients with smaller
lesions is using local tumescent anaesthesia. By diluting lidocaine
and epinephrine with normal saline, a larger area can be numbed
and radical surgery can be achieved. The addition of epinephrine
limits blood loss via vasoconstriction.
We found an overall relapse rate of 23.7%, which is slightly
lower compared with previous studies.17,18 Interestingly, none of
the patients treated with biologics experienced a relapse. All sur-
gical procedures were performed by the same dermatologist,
with years of experience in performing this technique. One could
therefore expect a slightly lower recurrence rate. However, the
mean follow-up was relatively short. Longer follow-up time
could have resulted in similar relapse rate compared with other
studies. More importantly, surgical skills need to be practiced
continuously; therefore, education and training is mandatory in
HS surgery.
All patient-reported outcomes demonstrated similar trends: a
modest increase in scores at first, which translates to worsening
of, e.g., quality of life, followed by a steady decrease, thus
improvement. The high DLQI score at baseline confirms the
enormous impact of HS on quality of life once again. For the
DLQI, the increase lasted until the third month, before declining
to baseline value at 6 months. Notably, the average amount of
days before wound closure was 81 days (2.7 months), which is
accompanied by daily wound care, pain and reduced mobility.
This might explain the trend of DLQI scores and why we did not
find a significant decrease in DLQI score compared with base-
line. A significant decrease in DLQI scores was found in the ret-
rospective study of Posch et al.6 where patients with Hurley
stage III had wide local excision (n = 74) and a minimum fol-
low-up period of 6 months.
Kofler et al. carried out a retrospective survey study of 255 HS
patients with Hurley stage III, who underwent wide local exci-
sion between 2006 and 2015. The majority of patients experi-
enced impairment of their everyday life (97%) and of their
professional life (60%) before surgery. These findings are com-
parable for our study, where almost 90% of patients experienced
impairment of everyday life at baseline. In both studies, these
percentages decreased after surgery.5 For the WPAI-HS, the
activity impairment showed a significant increase at week 2;
however, this rapidly improved to only a third of the value at
week 2 after 6 months. For overall work impairment, the
impairment nearly doubled after 2 weeks. Again, this also sub-
stantially improved at 6 month to less than a fifth of the impair-
ment at week two. Even though this was not significant after
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6 months, a positive trend is clear. Indicating that major surgery
improved work productivity and daily activity of these patients,
this has not been previously published.
Overall, 9 out of 39 subjects met the criteria for sexual dys-
function at one or more time points. Besides a modest improve-
ment in sexual health after 3 months, this effect did not seem to
sustain through the end of the study. In our study, the vast
majority of patients had moderate to severe HS, which likely
indicates several preceding years with active disease. This obser-
vation is in agreement with that of Janse et al.,3 who showed, that
the majority of patients with HS have the experience, that sexual
problems are not given enough attention by their physicians.
Summarizing, we found a significant influence of Hurley stage
and biologic treatment on TTWC, contrastingly not of smoking
and some improvement in work and activity impairment after
major surgery, which were not previously published. However, not
every aspect of the patients’ quality of life showed significant
changes after 6 months. It may be that a single procedure with only
6 months of follow-up might not suffice for either improving or
detecting a considerable change in sexual health or other aspects of
quality of life. Our results indicate the need for a more comprehen-
sive approach, if the goal is to improve the patients’ quality of life.
This study had some limitations, because of its small sample size
and relatively short follow-up period. The number of participants
might be too small to draw hard conclusions concerning the
TTWC and influencing parameters. A larger prospective study
with longer follow-up period is needed to confirm our findings.
Another limitation of this study is that TTWC was not evaluated
using matched pairs. The 6-month follow-up period evidently was
too short to adequately assess change in general quality of life and
sexual health in a skin disease with a long history. Unfortunately,
only a quarter of the respondents completed the entire survey for
all time points, which could influence our current findings.
Conclusion
Our results show a considerable negative influence of Hurley
stage III, treatment with biologics and wound surface on time to
wound closure after major surgery. The time of wound closure
was surprisingly not influenced by smoking. Furthermore, we
found acceptable recurrence rates and an improvement in over-
all work activity and improvement in activity impairment after
surgery. Future long-term studies on the effect of major surgery
on the quality of life in HS are needed.
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